Nupur Mittal to Adolescent
This is a "connection" page, showing publications Nupur Mittal has written about Adolescent.
Connection Strength
0.739
-
Shared barriers and facilitators to enrollment of adolescents and young adults on cancer clinical trials. Sci Rep. 2022 03 09; 12(1):3875.
Score: 0.132
-
Barriers to Pediatric Oncologist Enrollment of Adolescents and Young Adults on a Cross-Network National Clinical Trials Network Supportive Care Cancer Clinical Trial. J Adolesc Young Adult Oncol. 2022 02; 11(1):117-121.
Score: 0.124
-
A Tri-Institutional Approach to Address Disparities in Children's Oncology Group Clinical Trial Accrual for Adolescents and Young Adults and Underrepresented Minorities. J Adolesc Young Adult Oncol. 2019 06; 8(3):227-235.
Score: 0.106
-
Steroid Responsive Atypical Hemolytic Uremic Syndrome Triggered by Influenza B Infection. J Pediatr Hematol Oncol. 2019 01; 41(1):e63-e67.
Score: 0.105
-
A unique description of stage IV extranodal marginal zone lymphoma (EMZL) in an adolescent associated with gamma heavy chain disease. Pediatr Blood Cancer. 2015 May; 62(5):905-8.
Score: 0.081
-
Children's Oncology Group 2023 blueprint for research: Adolescent and young adult oncology. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30564.
Score: 0.036
-
Adolescent and young adult cancers: unmet needs and closing the gaps. Curr Opin Pediatr. 2023 02 01; 35(1):84-90.
Score: 0.034
-
Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative). Curr Probl Cancer. 2023 Dec; 47(6):100898.
Score: 0.034
-
Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network. JCO Oncol Pract. 2022 03; 18(3):224-231.
Score: 0.032
-
The Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network: A New Model for Addressing Site-Level Factors Impacting Clinical Trial Enrollment. J Adolesc Young Adult Oncol. 2020 08; 9(4):522-527.
Score: 0.029
-
The Moonshot Initiative: Randomized, Controlled Trials, and Its Impact in Pediatric Oncology. J Pediatr Hematol Oncol. 2018 07; 40(5):413-414.
Score: 0.025